Ocrelizumab: What to Know About the First Agent Approved for Primary Progressive MS
In this five-minute video, MS specialist Robert Bermel, MD, distills the essentials about how this new agent works, what makes it unique and what it achieved in pivotal trials.
Видео Ocrelizumab: What to Know About the First Agent Approved for Primary Progressive MS канала Cleveland Clinic
Видео Ocrelizumab: What to Know About the First Agent Approved for Primary Progressive MS канала Cleveland Clinic
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology
B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
Progressive MS featuring Dr. Benjamin Segal
Neil deGrasse Tyson Explains Nothing
What You Need to Know About Mavenclad®
What You Need to Know About Ocrevus
Ocrevus Side Effects Explained by Neurologist
Fatigue and myeloma
Neil—The Beginning of My MS Journey
How I’m Living My Best Life with Multiple Sclerosis | Robin Brockelsby | TEDxUniversityofNevada
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
Primary Progressive MS - Ben Thrower, M.D. - May 2017
Multiple Sclerosis - The State of the Art
MS: A Most Unusual Disease - Ben Thrower, M D - September 2015
What you need to know about Mayzent® (siponimod)
Keep Memory Alive - Frontotemporal Dementias
Tysabri, Ocrevus and Lemtrada! Oh MY! 2019 Updates
Ocrelizumab Use in Treating Multiple Sclerosis
Multiple sclerosis | Understanding the roles of B cells
Gagnant contre la sclérose en plaques - Dominique Guyaux